Health Systems Innovation Lab
The Health Systems Innovation Lab is a global research and training lab that specializes in health system performance, health policy, and venture creation.
677 Huntington Ave,
Boston, MA 02115
Building 1, 11th floor
Transitioning to High-Value Health Systems in G20+ Countries
The report highlights G20+ nations’ challenges with rising healthcare costs and disparities. Their goal is efficient, equitable, and effective healthcare. Despite efforts, no major population-level impact is seen. Harvard’s HSIL introduces a 10-component High-Value Health System Model. While countries have adopted parts of this model, none have fully realized it.
Scientific Publications
Global Burden of Disease Study 2021 estimates: implications for health policy and research
No abstract available
Enhancing global access to diabetes medicines: policy lessons from the HIV response
One of the biggest global health success stories is the response to the HIV pandemic over the past three decades. Scientists, clinicians, activists, policy makers, and pharmaceutical companies…
Tsinghua-Lancet Commission on health and poverty alleviation in China
No abstract available
Health service readiness to provide care for HIV and cardiovascular disease risk factors in low- and middle-income countries
Cardiovascular disease risk factors (CVDRF), in particular diabetes and hypertension, are chronic conditions which carry a substantial disease burden in Low- and Middle-Income Countries. Unlike HIV…
Health system resilience: a critical review and reconceptualisation
This Viewpoint brings together insights from health system experts working in a range of settings. Our focus is on examining the state of the resilience field, including current thinking on definition
Strengthening Health Systems To Face Pandemics: Subnational Policy Responses To COVID-19 In Latin America
Nonpharmaceutical interventions such as stay-at-home orders continue to be the main policy response to the COVID-19 pandemic in countries with limited or slow vaccine rollout. Often…
Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys<br>
As the prevalence of hypercholesterolemia is increasing in low- and middle-income countries (LMICs), detailed evidence is urgently needed to guide the response of health systems to this epidemic…
Reports
Transitioning to High-Value Health Systems in G20+ Countries
This report highlights and studies a major trend already underway in most health systems:
the imperative to achieve better health outcomes and curb rising healthcare costs…
The 2024 Report on "Transitioning To High-Value Health Systems in the G20+ Countries
In our second annual report of ‘Transitioning to High Value Health Systems’, we extend our
prior analysis to explore how G20+ countries are embracing a value orientation and the
policies, programs…